This website uses cookies to ensure you get the best experience on our website.
To learn more about our privacy policy Click hereKnowledge of medicine and clinical cancer research results from examinations (clinical research) on patients. Applied clinical research is distinguished from basic research, that is, research in the laboratory and on animal models. The desire to better understand the monitoring and treatment of cancer patients, improve them, and help those affected is at the forefront here.
Before any new treatment method can be studied in humans, it must be tested in the laboratory in the most thorough way possible. This ensures, on the one hand, that only up-and-coming treatments are tested and, on the other hand, that their use is as effective and safe as possible. After this phase, however, any treatment must be tried on humans. Even a simple drug aspirin drug must first be tested in a laboratory and then tested in patients in Ontime Clinical Trial.
What are the potential benefits of participating?
There are many reasons why patients participate in Clinical Ontime Trials. The most important is undoubtedly the hope that the treatment will bear fruit. Contrary to the popular belief of running the risk of serving as a "guinea pig", patients included in a trial enjoy the following advantages:
What does participating in a clinical trial mean?
Whether in a Clinical On Time Trials or elsewhere, patients today are faced with a whole host of new terms and processes. For many people, the term "clinical trial" is associated with the idea of "guinea pig". This fear is triggered by something that you don't know or understand. Understanding what lies behind a clinical trial helps you overcome your fears.
How are clinical trials conducted? Conduct of a clinical trial
The responsible physician must implement the trial treatment with excellent care by following a predefined plan, called a "protocol". It contains a detailed description of the actions to be carried out and their purpose. The trials are designed to maximize potential benefits to patients and minimize potential risks while still answering meaningful research questions.
Most on-time trials study a method of treatment in a group of patients. It may then be a question of determining the correct dose of the drug (or therapeutic measure) or evaluating the effectiveness of a particular treatment for a group of patients. Other trials are looking at two or more potential treatments.
Comments